Hospital-based influenza and pneumococcal vaccination: Sutton's Law applied to prevention.
TLDR
This commentary will address the following six issues: the epidemiological rationale for hospitalbased influenza and pneumococcal vaccination; the translation of these epidemiological findings into clinical and public policy; changes in the scientific understanding of the benefits of influenza and pneumoniae vaccination; experience in implementing hospitalbased programs for vaccination; practical issues for hospital-based vaccination; and an enhanced role for infection control practitioners in ensuring that Sutton’s Law for influenza and lung cancer vaccination is followed.Abstract:
Pneumonia and influenza continue to be two of the major causes of hospitalization and death throughout the world. It is fitting that this issue of the Journal is devoted to addressing these important topics. Many of these cases are caused by influenza virus and Streptococcus pneumoniae and could be prevented if the delivery of influenza and pneumococcal vaccines were more effectively targeted to those individuals who are otherwise destined to be hospitalized or to die due to one of these diseases. That persons with vaccine-preventable influenza and pneumococcal infections are still admitted to our hospitals is a sobering reminder that there still is important work to do. Early in their education, virtually all medical students are taught the importance of following Sutton’s Law in formulating a differential diagnosis. Sutton’s Law is based on the remark made by the notorious bank robber, Willie Sutton. When asked why he robbed banks, he replied, “That’s where the money is.” In formulating a differential diagnosis, the student is advised to think first of common problems, not rare diseases. More often than not, diagnosing a common problem is “where the money is.” Sutton’s Law also can be applied to the prevention of influenza and pneumococcal infections. In this instance, the question asked is, “What is the best vaccination strategy for reaching people who, if not vaccinated, will have the greatest likelihood of being hospitalized or dying of these two diseases?” The answer is patients who are being discharged from the hospital. Hospital-based influenza and pneumococcal vaccination is “where the money is.” In this commentary, we will address the following six issues: (1) the epidemiological rationale for hospitalbased influenza and pneumococcal vaccination; (2) the translation of these epidemiological findings into clinical and public policy; (3) changes in the scientific understanding of the benefits of influenza and pneumococcal vaccination; (4) experience in implementing hospitalbased programs for vaccination; (5) practical issues for hospital-based vaccination; and (6) an enhanced role for infection control practitioners in ensuring that Sutton’s Law for influenza and pneumococcal vaccination is followed.read more
Citations
More filters
Journal Article
Improving Immunization Rates Using Lean Six Sigma Processes: Alliance of Independent Academic Medical Centers National Initiative III Project
TL;DR: This process improvement project was not only beneficial in terms of improved quality of patient care but was also a positive learning experience for the interdisciplinary team, particularly for the residents.
Journal ArticleDOI
Influenza and pneumococcal vaccination coverage levels among Hawaii statewide long-term-care facilities.
TL;DR: Influenza and pneumococcal vaccination rates among Hawaii long-term-care facilities (LTCFs) statewide during the 1996/97 through the 1998/99 influenza seasons revealed that resident influenza vaccination rates remained over 89%, but pneumococCal vaccination was underutilized.
Journal ArticleDOI
Brief Report: Quality Improvement in Critical Access Hospitals: Addressing Immunizations Prior to Discharge
Edward F. Ellerbeck,Bonnie Totten,Samuel J. Markello,Kelly L. Patterson,Thomas R. Sipe,Chris Tilden +5 more
TL;DR: Critical access hospitals can effectively participate in quality improvement activities, but increased involvement of medical staff or standing immunization orders may be needed to improve actual vaccine administration prior to discharge.
Journal ArticleDOI
Influenza Vaccination of Healthcare Personnel
Journal ArticleDOI
Pneumococcal polysaccharide vaccination in Australia: an examination of barriers and arguments in support of the hospital based approach.
TL;DR: Since 2005 a publicly funded program offering free pneumococcal polysaccharide vaccine for at-risk patients has been implemented in Australia, and early data suggest that this change has had a major positive impact on pneumococCal vaccination rates, however, rates still remain far below the ideal.
References
More filters
Journal ArticleDOI
The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.
TL;DR: For elderly citizens living in the community, vaccination against influenza is associated with reductions in the rate of hospitalization and in deaths from influenza and its complications, as compared with the rates in unvaccinated elderly persons, and vaccination produces direct dollar savings.
Book
Prevention and Control of Nosocomial Infections
TL;DR: The role of the hospital epidemiologist in protecting the environment laboratory-acquired infections infectious biohazards associated with laboratory animal research nosocomial infections related to patient care support and protection from blood and blood products.
Journal ArticleDOI
Reviews of evidence regarding interventions to improve vaccination coverage in children adolescents and adults.
Peter A. Briss,Lance E. Rodewald,Alan R. Hinman,Abigail Shefer,Raymond A. Strikas,Roger R. Bernier,Vilma G Carande-Kulis,Hussain R. Yusuf,Serigne M. Ndiaye,Sheree Marshall Williams +9 more
TL;DR: In this paper, the authors present the results of systematic reviews of the effectiveness, applicability, other effects, economic impact, and barriers to use of selected population-based interventions intended to improve vaccination coverage.
Journal ArticleDOI
Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.
TL;DR: It is confirmed that healthy senior citizens as well as senior citizens with underlying medical conditions are at risk for the serious complications of influenza and benefit from vaccination.